3-Amino-1-adamantanol is an important 1,3-disubstituted adamantane-like drug intermediate, such as used to synthesize oral anti-type 2 diabetes drug LAF237 (US20080167479A1).
3-Amino-1-adamantanol is an organic synthesis intermediate and pharmaceutical intermediate. It can be used in the laboratory organic synthesis process and the chemical medicine research and development process. It is mainly used to synthesize adamantane derivative drugs to treat type 2 diabetes.